Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense oligonucleotides.

B Calabretta1, T Skorski, G Zon

  • 1Jefferson Cancer Institute, Thomas Jefferson University, Philadelphia, PA 19107.

Seminars in Cancer Biology
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia.

Leukemia·2016
Same author

Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes.

Cell death & disease·2016
Same author

CDKN2A-independent role of BMI1 in promoting growth and survival of Ph+ acute lymphoblastic leukemia.

Leukemia·2016
Same author

AKT-induced reactive oxygen species generate imatinib-resistant clones emerging from chronic myeloid leukemia progenitor cells.

Leukemia·2014
Same author

Anti-oxidant vitamin E prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice.

Leukemia·2013
Same author

BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability.

Leukemia·2012
Same journal

Role of oral microbiome in cancer immunotherapy.

Seminars in cancer biology·2026
Same journal

Unveiling tumor heterogeneity by single cell RNA-sequencing: From basic considerations to clinical applications.

Seminars in cancer biology·2026
Same journal

Hidden architecture of resistance: The extracellular matrix in melanoma's immune landscape.

Seminars in cancer biology·2026
Same journal

Microfluidic technologies for extracellular vesicle isolation and analysis: Implications for translational applications in cancer therapy.

Seminars in cancer biology·2026
Same journal

Exploring glioblastoma microenvironment using organoids: opportunities, limitations, and emerging concepts.

Seminars in cancer biology·2026
Same journal

Special issue: Lipid metabolic alterations in cancer: Pathogenic mechanisms, therapies and common pathophysiology with cardiovascular disease.

Seminars in cancer biology·2026
See all related articles

Antisense oligodeoxynucleotides can inhibit gene expression to study cell proliferation. While effective in the short term for tumor growth, their long-term therapeutic use requires further study.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Antisense oligodeoxynucleotides (ASOs) are tools for gene expression inhibition.
  • Oncogene activation drives tumor initiation and progression.
  • Targeting oncogenes may selectively inhibit tumor cell proliferation.

Purpose of the Study:

  • To explore the potential of antisense oligodeoxynucleotides in cancer therapy.
  • To evaluate the efficacy of gene expression inhibition in controlling abnormal cell proliferation.

Main Methods:

  • Utilizing antisense oligodeoxynucleotides to specifically inhibit gene expression.
  • Assessing the effects on tumor cell proliferation in vitro.
  • Investigating the potential for selective inhibition of cancer cells.

Related Experiment Videos

Main Results:

  • ASOs demonstrate short-term in vitro efficacy in inhibiting tumor growth.
  • Down-regulation of oncogene expression shows promise in targeting cancer cells.
  • Evidence supports ASOs as tools for understanding gene function.

Conclusions:

  • ASOs are valuable for studying gene function and their role in abnormal cell proliferation.
  • Short-term in vitro results are promising for cancer therapy.
  • Further research is needed to confirm long-term effects and pharmacological properties for therapeutic use.